{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "Amount",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uaz:UAZ03736",
      "entity_text" : "IRI",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false,
    "context" : {
      "TissueType" : [ "tissuelist:TS-0079" ],
      "Species" : [ "taxonomy:9606" ]
    }
  },
  "verbose_text" : "Compared with patients with cognitive impairment alone, those with both cognitive impairment and cancer had higher levels of BS (213.769 +/- 51.134 vs. 160.429 +/- 51.831 mg/dL) and IRI (11.700 +/- 2.653 vs. 8.993 +/- 4.739 muU/mL).",
  "reading_complete" : "2020-08-03T15:56:14Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-03T15:55:32Z",
  "trigger" : "levels",
  "evidence" : [ "levels of BS (213.769 +/- 51.134 vs. 160.429 +/- 51.831 mg/dL) and IRI" ],
  "pmc_id" : "6819519",
  "score" : 0
}